4.5 Interaction with other medicinal products and other forms of interaction 
 No interaction studies have been performed  with Yescarta. 
 Prophylactic use of systemic corticosteroids may interfere with the activity of  Yescarta. Prophylactic use of systemic corticosteroids is therefore not recommended before infusion (see section  4.2).  
 Administration of corticosteroids as per the toxicity management guidelines does not impact the expansion and persistence of CAR T cells.  
 Live vaccines  
 The safety of immunisation with live viral vaccines during or following treatment with Yescarta  has not been studied.  As a precautionary measure, v accination with live vaccines is not recommended for at least 6  weeks prior to the start of lymphodepleting chemotherapy, during Yescarta treatment, and until immune recovery following treatment . 
 